Heungkuk Asset Management
VC Fund
Seoul, South Korea
Heungkuk Asset Management is a financial services firm that specializes in stocks, fixed income, mixed assets, and hedge funds, and others.
- Total investments:
- 17
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Heungkuk Asset Management invests in
Stages Heungkuk Asset Management invests in
Countries Heungkuk Asset Management invests in
Investment Focus
Industry
- Biotechnology 7 (41%)
- Therapeutics 4 (24%)
- Pharmaceutical 3 (18%)
- Health Care 2 (12%)
- Manufacturing 2 (12%)
Stage
- Series B 4 (24%)
- Series A 3 (18%)
- Series C 2 (12%)
- Seed 1 (6%)
- Private Equity 1 (6%)
Country
- South Korea 10 (59%)
- United States 1 (6%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Nventric
|
Nventric is a medical device company that develops core products for neurovascular, coronary heart, and peripheral vascular applications. | $22.6M / Venture - Series Unknown / Jun 10, 2026 | |
Novacos
|
Novacos develops cosmetic and skincare products through OEM and ODM manufacturing. The company handles formulation development, product production, packaging, quality control, and private-label cosmetics services. | $1.4M / Seed / Oct 01, 2025 | |
CURAUM
|
CURAUM is a specialist in oral care and sleep-related health care products. | $14.6M / Series C / May 25, 2025 | |
Global Technologies
|
Global Technologies specializes in developing core sensors and advanced sensor systems. Leveraging proprietary semiconductor and software technology, they provide high-performance solutions for environmental sensing and industrial applications. Based in Korea, the company focuses on innovation in sensor hardware to enable smarter data collectionand automation across various global markets. | $9.4M / Series A / Jul 04, 2024 | |
Avelos Therapeutics
|
Avelos Therapeutics is a precision medicine company in the clinical stage that finds, creates, and sells targeted therapeutics. | $12.4M / Series B / May 02, 2024 | |
DewCell
|
Dewcell Biotherapeutics develops synthetic platelets using biomimetic technology. The company's system secures stem cell differentiation technology into megakaryocytes that generate platelets and mass-produces artificial platelets. | $6.6M / Series B / Apr 29, 2024 | |
Artblood
|
ArtBlood is a biotechnology company that offers cell-based artificial blood production and regenerative medicine. The company develops innovative in vitro red blood cell (RBC) production technologies using stem cell–based platforms. | $4.8M / Series A / Apr 09, 2024 | |
BioResearchAI
|
BioResearchAI is a research platform that provides bio-healthcare field database with AI technology for researchers. The company provides virtual wardrobe management, outfit recommendations, and digital fashion experiences to improve online and in-store shopping experiences. | $1.5M / Seed / Apr 02, 2024 | |
|
Nventric
|
Nventric is a medical device company that develops core products for neurovascular, coronary heart, and peripheral vascular applications. | $10.5M / Series B / Feb 06, 2024 | |
DAAN Biotherapeutics
|
DAAN Biotherapeutics develops novel treatments for cancer patients. The company conducts cancer treatment research and development, including cell therapies, antibodies, and small molecule inhibitors. | $17.2M / Series A / Jan 25, 2024 | |
| See all 17 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Heungkuk Asset Management invest in?
Heungkuk Asset Management invests primarily in Biotechnology, Therapeutics and Pharmaceutical startups, most often at Series B and Series A stage. Most of the 17 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Heungkuk Asset Management last invest?
The most recent investment recorded for Heungkuk Asset Management closed in Jun 2026. Shizune tracks 17 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
